K Health, Mayo Clinic collaborate on AI-powered hypertension treatments

K Health, an AI-powered healthcare company, has teamed up with Mayo Clinic Platform for personalized hypertension treatment. 

Mayo Clinic Platform is a digital healthcare initiative of Mayo Clinic that uses new knowledge, solutions and technologies to improve patients' lives. K Health will utilize de-identified medical data from Mayo Clinic Platform_Discover, enabling primary care physicians to leverage real-time insights for a predictive model on K Health’s virtual platform to treat hypertension personally. The real-time model curates de-identified Mayo Clinic patient data from Discover, which includes demographics, medical history, lab results, medications prescribed, outcomes and more.

Hypertension is one of the most common chronic conditions in the U.S., but treatment can be complex with multiple medications or lifestyle changes. The predictive model can help physicians find a more targeted, intelligent, personalized approach for treating hypertension, according to K Health.

“It is amazing to think that doctors located all over the U.S. can access knowledge from Mayo Clinic clinicians to combat one of our country’s most dire primary care conditions,” Ran Shaul, chief product officer and co-founder of K Health and Hydrogen Health, said in a statement. “Together with Mayo Clinic Platform we want to change the way people receive healthcare, and we can’t wait to see what other conditions we can treat with the Discover product as part of our algorithm solution.”

K Health is one of the largest virtual primary care providers in the country, with hundreds of board-certified internists on its platform. The company has clinicians licensed in 48 states practicing on its platform. K Health also meets demand through its enterprise solution Hydrogen Health, which is also a joint venture between Anthem, Blackstone and K Health.

“With less trial and error when it comes to hypertension treatment, we have the potential to not only improve quality of life and outcomes, but also decrease medical costs for thousands of people,” said Edo Paz, MD, cardiologist and vice president of medical at K Health. “This novel platform will give clinicians practicing on the K Health platform a way to more confidently and efficiently treat their patients.”
 

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Trimed Popup
Trimed Popup